Add to ORKGThird generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patient
Endocrine therapy plays a crucial and historically important role in the treatment of women with hor...
Tamoxifen, a selective estrogen receptor modulator (SERM), has been used for many decades as the "go...
Tamoxifen, a selective estrogen receptor modulator (SERM), has been used for many decades as the "go...
INTRODUCTION: The gynaecological toxicity profile of tamoxifen presents a significant burden to the ...
Abstract Endometriosis is defined as the growth of endometrial tissue outside of the uterine cavity....
Tamoxifen has been the gold standard adjuvant therapy for the treatment of postmenopausal women with...
Aromatase inhibitor (AI) therapy is the current preferred choice of endocrine therapy in postmenopau...
Purpose: Type I endometrial cancer is a common tumor of the female genital tract. Since in post-meno...
Oestrogen receptors are expressed in 2/3rd of all breast cancers and the oestrogen mediated growth s...
Reva Schneider1, Ayman Barakat1, John Pippen1,2,3, Cynthia Osborne1,2,3 1Medical Oncology, Baylor-Sa...
used to predict risk of invasive breast cancer (including both estro-gen receptor [ER] – positive a...
BackgroundBoth endometrial cancer and postmenopausal breast cancer risk are increased by obesity and...
BackgroundThe risks of both endometrial cancer and postmenopausal breast cancer are increased by obe...
Background. Aromatase inhibitors (AIs) are more effec-tive than tamoxifen as neoadjuvant endocrine t...
Estrogens play important roles in breast cancer development and progression. In postmenopausal women...
Endocrine therapy plays a crucial and historically important role in the treatment of women with hor...
Tamoxifen, a selective estrogen receptor modulator (SERM), has been used for many decades as the "go...
Tamoxifen, a selective estrogen receptor modulator (SERM), has been used for many decades as the "go...
INTRODUCTION: The gynaecological toxicity profile of tamoxifen presents a significant burden to the ...
Abstract Endometriosis is defined as the growth of endometrial tissue outside of the uterine cavity....
Tamoxifen has been the gold standard adjuvant therapy for the treatment of postmenopausal women with...
Aromatase inhibitor (AI) therapy is the current preferred choice of endocrine therapy in postmenopau...
Purpose: Type I endometrial cancer is a common tumor of the female genital tract. Since in post-meno...
Oestrogen receptors are expressed in 2/3rd of all breast cancers and the oestrogen mediated growth s...
Reva Schneider1, Ayman Barakat1, John Pippen1,2,3, Cynthia Osborne1,2,3 1Medical Oncology, Baylor-Sa...
used to predict risk of invasive breast cancer (including both estro-gen receptor [ER] – positive a...
BackgroundBoth endometrial cancer and postmenopausal breast cancer risk are increased by obesity and...
BackgroundThe risks of both endometrial cancer and postmenopausal breast cancer are increased by obe...
Background. Aromatase inhibitors (AIs) are more effec-tive than tamoxifen as neoadjuvant endocrine t...
Estrogens play important roles in breast cancer development and progression. In postmenopausal women...
Endocrine therapy plays a crucial and historically important role in the treatment of women with hor...
Tamoxifen, a selective estrogen receptor modulator (SERM), has been used for many decades as the "go...
Tamoxifen, a selective estrogen receptor modulator (SERM), has been used for many decades as the "go...